FK 906
Alternative Names: FR 115906Latest Information Update: 23 Jun 1998
At a glance
- Originator Fujisawa
- Class Antihypertensives
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 16 Jan 1996 Discontinued-I for Hypertension in European Union (Unknown route)
- 16 Jan 1996 Discontinued-II for Hypertension in Japan (Unknown route)